Featured speaker Feyi Olopade Ayodele, CEO and Co-Founder of CancerIQ, led a recent workshop at the Association of Cancer Executives 2020 Annual Meeting. In this session, we covered the best practices for starting a program, growing volumes in your program, and increasing service capacity for genetic specialists. We also covered the important financial considerations and getting buy-in from leadership. 

Below is a short highlight video of her talk.

To view the whole presentation and receive the PPT slides, simply fill out the form and we'll send it over. 

Featured Speaker:

Feyi Olopade Ayodele is the Co-Founder and Chief Executive Officer at CancerIQ. The CancerIQ platform has been rapidly adopted by some of the top health systems across the country including Adventist Health, CHRISTUS Health, Sharp Healthcare, and many more. In 2019, Ayodele was named to Crain’s Chicago Business 40 under 40 list for her work in expanding genetic services.

Ayodele is featured in publications such as Genome Web, The American Journal of Managed Care, MedCity News and has been invited to speak at multiple conferences including ACE, ACCC and Cleveland Clinic’s Medical Innovation Summit. Prior to CancerIQ, Ayodele worked as a management consultant, investor, and investment banker at McKinsey, Actis LLP, and Credit Suisse. Ayodele received both her Bachelor’s and MBA from The Wharton School.